DRUG · Mapped RxNorm record
Anastrozole
Normalized identity: anastrozoleView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
T-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast Cancer
NCT03554044
Drugs and interventions used in this trial
10 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Exemestane
Normalized identity: exemestaneView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Fulvestrant
Normalized identity: fulvestrantView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Letrozole
Normalized identity: letrozoleView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Paclitaxel
Normalized identity: paclitaxelView linked drug · Find medicine records ·
Find other trials using this name
BIOLOGICAL · Unmapped registry intervention
Talimogene Laherparepvec
Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Tamoxifen
Normalized identity: tamoxifenView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
Nab paclitaxel
Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Gemcitabine
Normalized identity: gemcitabineView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Carboplatin
Normalized identity: carboplatinView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedT-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast Cancer
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Anatomic Stage III Breast Cancer AJCC v8unresolved
Anatomic Stage IV Breast Cancer AJCC v8unresolved
Estrogen Receptor Positiveunresolved
HER2/Neu Negativeunresolved
Recurrent Breast Carcinomaunresolved
Interventions
AnastrozoleDRUG · verified · RxNorm: anastrozole
ExemestaneDRUG · verified · RxNorm: exemestane
FulvestrantDRUG · verified · RxNorm: fulvestrant
LetrozoleDRUG · verified · RxNorm: letrozole
PaclitaxelDRUG · verified · RxNorm: paclitaxel
Talimogene LaherparepvecBIOLOGICAL
TamoxifenDRUG · verified · RxNorm: tamoxifen
Nab paclitaxelDRUG
GemcitabineDRUG · verified · RxNorm: gemcitabine
CarboplatinDRUG · verified · RxNorm: carboplatin
Sponsors & collaborators
University of California, San Franciscolead sponsor
Amgencollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03554044 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.